The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Marco Onofrj

Department of Neurology

University G. d'Annunzio of Chieti-Pescara

Italy

[email]@unich.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Neurology, University G. d'Annunzio of Chieti-Pescara, Italy. 1996 - 2010
  • University G D'Annunzio of Chieti-Pescara, University Foundation 'G D'Annunzio', Department of Oncology and Neuroscience, Ageing Research Center, Italy. 2008
  • University G. D'Annunzio, Department of Neurophysiopathology, Chieti-Pescara, 65124, Italy. 2007
  • Neurophysiopathology, University Chieti-Pescara, Pescara, Italy. 2004
  • Servizio di Neurofisiopatologia, Pescara, Italy. 2004

References

  1. Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies. Onofrj, M., Bonanni, L., Manzoli, L., Thomas, A. Neurology (2010) [Pubmed]
  2. Long half-life and prolonged-release dopamine receptor agonists: a review of ropinirole prolonged-release studies. Onofrj, M., Bonanni, L., De Angelis, M.V., Anzellotti, F., Ciccocioppo, F., Thomas, A. Parkinsonism Relat. Disord. (2009) [Pubmed]
  3. Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment. Onofrj, M., Bonanni, L., Cossu, G., Manca, D., Stocchi, F., Thomas, A. Parkinsonism Relat. Disord. (2009) [Pubmed]
  4. An expert opinion on safinamide in Parkinson's disease. Onofrj, M., Bonanni, L., Thomas, A. Expert. Opin. Investig. Drugs (2008) [Pubmed]
  5. New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins. Onofrj, M., Thomas, A., Bonanni, L. Expert. Rev. Neurother (2007) [Pubmed]
  6. Visual hallucinations in Parkinson's disease: clues to separate origins. Onofrj, M., Bonanni, L., Albani, G., Mauro, A., Bulla, D., Thomas, A. J. Neurol. Sci. (2006) [Pubmed]
  7. Acute akinesia in Parkinson disease. Onofrj, M., Thomas, A. Neurology (2005) [Pubmed]
  8. Clinically evidenced unilateral dissociation of saccades and pursuit eye movements. Onofrj, M., Iacono, D., Luciano, A.L., Armellino, K., Thomas, A. J. Neurol. Neurosurg. Psychiatr. (2004) [Pubmed]
  9. Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson's Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study. Onofrj, M., Thomas, A., Vingerhoets, F., Martin, W., Giménez-Roldán, S., Azulay, J.P., Bernhard, G., Schmidt, W., Markabi, S. J. Neural. Transm (2004) [Pubmed]
  10. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Onofrj, M., Luciano, A.L., Thomas, A., Iacono, D., D'Andreamatteo, G. Neurology (2003) [Pubmed]
  11. HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease. Onofrj, M., Luciano, A.L., Iacono, D., Thomas, A., Stocchi, F., Papola, F., Adorno, D., Di Mascio, R. Mov. Disord. (2003) [Pubmed]
  12. The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia. Onofrj, M., Thomas, A., Iacono, D., Luciano, A.L., Di Iorio, A. Clin. Neuropharmacol (2003) [Pubmed]
  13. Severe worsening of parkinsonism in Lewy body dementia due to donepezil. Onofrj, M., Thomas, A. Neurology (2003) [Pubmed]
  14. Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease. Onofrj, M., Thomas, A., Luciano, A.L., Iacono, D., Di Rollo, A., D'Andreamatteo, G., Di Iorio, A. Clin. Neuropharmacol (2002) [Pubmed]
  15. Age-related changes of evoked potentials. Onofrj, M., Thomas, A., Iacono, D., D'Andreamatteo, G., Paci, C. Neurophysiol. Clin (2001) [Pubmed]
  16. Delayed and pseudodelayed visual evoked potentials in optic neuritis compared with long time echo-short tau inversion recovery magnetic resonance imaging of optic nerve. Onofrj, M., Fulgente, T., Thomas, A., Gambi, D., Melchionda, D., Lopez, L. Electroencephalogr. Clin. Neurophysiol (1996) [Pubmed]
  17. Altitudinal visual stimuli and the cruciform model of evoked potentials. Onofrj, M., Fulgente, T., Thomas, A., Curatola, L., Mastropasqua, L., Locatelli, T., Martinelli, V., Comi, G. Electroencephalogr. Clin. Neurophysiol. Suppl (1996) [Pubmed]
 
WikiGenes - Universities